232 related articles for article (PubMed ID: 10887303)
1. The use of standardized extracts in allergen immunotherapy.
Nelson HS
J Allergy Clin Immunol; 2000 Jul; 106(1 Pt 1):41-5. PubMed ID: 10887303
[TBL] [Abstract][Full Text] [Related]
2. Survey on immunotherapy practice patterns: dose, dose adjustments, and duration.
Larenas-Linnemann DE; Gupta P; Mithani S; Ponda P
Ann Allergy Asthma Immunol; 2012 May; 108(5):373-378.e3. PubMed ID: 22541411
[TBL] [Abstract][Full Text] [Related]
3. Specific immunotherapy with allergen mixes: what is the evidence?
Nelson HS
Curr Opin Allergy Clin Immunol; 2009 Dec; 9(6):549-53. PubMed ID: 19745727
[TBL] [Abstract][Full Text] [Related]
4. How's my dosing? A one-step, math-free guide for comparing your clinic's maintenance immunotherapy doses to current practice parameter recommendations.
Grier TJ
Ann Allergy Asthma Immunol; 2012 Mar; 108(3):201-5. PubMed ID: 22374205
[TBL] [Abstract][Full Text] [Related]
5. European allergen extract units and potency: review of available information.
Larenas-Linnemann D; Cox LS;
Ann Allergy Asthma Immunol; 2008 Feb; 100(2):137-45. PubMed ID: 18320915
[TBL] [Abstract][Full Text] [Related]
6. Maintenance dosing for sublingual immunotherapy by prominent European allergen manufacturers expressed in bioequivalent allergy units.
Larenas-Linnemann D; Esch R; Plunkett G; Brown S; Maddox D; Barnes C; Constable D
Ann Allergy Asthma Immunol; 2011 Nov; 107(5):448-458.e3. PubMed ID: 22018618
[TBL] [Abstract][Full Text] [Related]
7. Comparison of allergen immunotherapy practice patterns in the United States and Europe.
Cox L; Jacobsen L
Ann Allergy Asthma Immunol; 2009 Dec; 103(6):451-59; quiz 459-61, 495. PubMed ID: 20084837
[TBL] [Abstract][Full Text] [Related]
8. Allergen immunotherapy practice in the United States: guidelines, measures, and outcomes.
Cox L; Esch RE; Corbett M; Hankin C; Nelson M; Plunkett G
Ann Allergy Asthma Immunol; 2011 Oct; 107(4):289-99; quiz 300. PubMed ID: 21962088
[TBL] [Abstract][Full Text] [Related]
9. [Allergen-specific immune therapy in the treatment of asthma].
Malling HJ
Ugeskr Laeger; 2000 Jan; 162(4):477-9. PubMed ID: 10697443
[TBL] [Abstract][Full Text] [Related]
10. Advances in upper airway diseases and allergen immunotherapy.
Nelson HS
J Allergy Clin Immunol; 2007 Apr; 119(4):872-80. PubMed ID: 17292953
[TBL] [Abstract][Full Text] [Related]
11. How important is proper dosing for subcutaneous and sublingual allergy immunotherapy?
Nelson HS
Allergy Asthma Proc; 2021 Sep; 42(5):368-377. PubMed ID: 34474706
[No Abstract] [Full Text] [Related]
12. Perception and practice of sublingual immunotherapy among practicing allergists.
Tucker MH; Tankersley MS;
Ann Allergy Asthma Immunol; 2008 Oct; 101(4):419-25. PubMed ID: 18939732
[TBL] [Abstract][Full Text] [Related]
13. Allergen immunotherapy practice patterns: a worldwide survey.
Ponda P; Mithani S; Kopyltsova Y; Sison C; Gupta P; Larenas D; Bonagura VR
Ann Allergy Asthma Immunol; 2012 Jun; 108(6):454-459.e7. PubMed ID: 22626600
[TBL] [Abstract][Full Text] [Related]
14. Effect of allergen immunotherapy practice parameters on cat extract prescribing patterns, 1993-2009.
Robertson BD; McCoy RL; Nelson MR; Haymore BR
Ann Allergy Asthma Immunol; 2011 Nov; 107(5):437-40. PubMed ID: 22018616
[TBL] [Abstract][Full Text] [Related]
15. Phleum pratense alone is sufficient for allergen-specific immunotherapy against allergy to Pooideae grass pollens.
Hejl C; Wurtzen PA; Kleine-Tebbe J; Johansen N; Broge L; Ipsen H
Clin Exp Allergy; 2009 May; 39(5):752-9. PubMed ID: 19222498
[TBL] [Abstract][Full Text] [Related]
16. European Academy of Allergy and Clinical Immunology task force report on 'dose-response relationship in allergen-specific immunotherapy'.
Calderón MA; Larenas D; Kleine-Tebbe J; Jacobsen L; Passalacqua G; Eng PA; Varga EM; Valovirta E; Moreno C; Malling HJ; Alvarez-Cuesta E; Durham S; Demoly P
Allergy; 2011 Oct; 66(10):1345-59. PubMed ID: 21707645
[TBL] [Abstract][Full Text] [Related]
17. [Reappraisal of inhalant allergens available for allergy practice in Japan. A need to increase allergen extracts available for immunotherapy].
Nagaya H
Arerugi; 1991 Jan; 40(1):60-4. PubMed ID: 2029221
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of specific immunotherapy with SQ allergen extract in treatment-resistant seasonal allergic rhinoconjunctivitis.
Frew AJ; Powell RJ; Corrigan CJ; Durham SR;
J Allergy Clin Immunol; 2006 Feb; 117(2):319-25. PubMed ID: 16461133
[TBL] [Abstract][Full Text] [Related]
19. Double-blind, placebo-controlled evaluation of grass pollen specific immunotherapy with oral drops administered sublingually or supralingually.
Panzner P; Petrás M; Sýkora T; Lesná I
Respir Med; 2008 Sep; 102(9):1296-304. PubMed ID: 18585908
[TBL] [Abstract][Full Text] [Related]
20. [New administration routes for immunotherapy].
Martorell Aragonés A
Allergol Immunopathol (Madr); 2000; 28(3):93-102. PubMed ID: 10867377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
